Developments in haematological malignancies
6 Jun 2016
Developments in haematological malignancies
MyPathway guidance of targeted therapy based on molecular profiles
Advanced RET-rearranged NSCLC
Update on olaparib in ovarian cancer
Impact of precision medicine in refractory malignancies
ASCO 2016: Plenary Session Review
Chemotherapy combination with capecitabine extends survival after pancreatic cancer surgery
Patient engagement in The Metastatic Breast Cancer Project
Use of novel agents in childhood ALL
Radiotherapy in Hogkin lymphoma: reducing risk in later life
Relapsed Hodgkin lymphoma in PET positive patients
Entrectinib, a novel treatment for TRK fusions, shows early promise against a range of cancer types